Peptide Drugs intermediate
Romosozumab: Oligopeptide Research Reference
Anti-sclerostin monoclonal antibody for osteoporosis stimulating formation and reducing resorption. This peptide or oligopeptide is studied for its biologica...
By Encyclopeptide Editorial | 1 min read
sclerostin osteoporosis monoclonal-antibody
Overview
Anti-sclerostin monoclonal antibody for osteoporosis stimulating formation and reducing resorption.
Structure
| Property | Value |
|---|---|
| Name | Romosozumab |
Mechanism of Action
Sclerostin inhibition simultaneously stimulates bone formation and reduces resorption.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | Romosozumab |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about Romosozumab: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept